PubMed ID: 42162248
Author(s): Korobelnik JF, Leal S, Lanzetta P; PULSAR study investigators. Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial. Eye (Lond). 2026 May 20. doi: 10.1038/s41433-026-04486-1. Epub ahead of print. PMID: 42162248.PMID 42162248
Journal: Eye (London)